In early August, the FDA issued a Class 2 Device Recall for Visibly’s Online Refraction Vision Test, stating that the company did not receive authorization from the FDA to market the product.
The American Optometric Association (AOA) has submitted a complaint to the US Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) over an online eye exam that may not ...
Please provide your email address to receive an email when new articles are posted on . Described as “a stenopaeic slit refraction system in a binocular telescopic optometer calibrated to measure ...